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Abstract 
Objectives: To compare and explore the dose-response of phytate-containing 1150 ppm fluoride 
toothpastes on model caries lesions and to determine the impact of zinc ions. 
Methods: This was a single-centre, randomised, blinded (examiner/laboratory analyst), six-
treatment, four-period crossover, in situ study in adults with a removable bilateral maxillary partial 
denture. Study treatments were toothpastes containing: 0.425% phytate/F; 0.85% phytate/F; 0.85% 
phytate/Zn/F; F-only; Zn/F and a 0% F placebo. Where present, F was 1150 ppm as NaF; Zn was 0.3% 
as ZnCl2. Human enamel specimens containing early-stage, surface-softened (A-lesions) or more 
advanced, subsurface (B-lesions) caries lesions were placed into the buccal flanges of participants’ 
modified partial denture (one of each lesion type per side). A-lesions were removed after 14 days of 
twice-daily treatment use; B-lesions were removed after a further 14 days. A-lesions were analysed 
for surface microhardness recovery. Both lesion types were analysed by transverse 
microradiography and for enamel fluoride uptake, with B-lesions additionally analysed by 
quantitative light-induced fluorescence. Comparison was carried out using an analysis of covariance 
model.  
Results: Statistically significant differences between 1150 ppm F and the placebo toothpastes 
(p<0.05) were shown for all measures, validating the model. No differences between fluoride 
toothpastes were observed for any measure with little evidence of a dose-response for phytate. 
Study treatments were generally well tolerated. 
Conclusions: Results suggest phytate has little impact on fluoride’s ability to promote early-stage 
lesion remineralisation or prevent more advanced lesion demineralisation in this in situ caries 
model. Similarly, results suggest zinc ions do not impair fluoride efficacy. 
 
Clinical significance: Toothpastes may contain therapeutic or cosmetic agents that could interfere 
with fluoride’s caries prevention efficacy. The present in situ caries study has demonstrated that 
phytate, added to provide enhanced extrinsic stain removal/prevention, and zinc, added to inhibit 
malodour, do not impair fluoride efficacy. 
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Introduction 
Modern toothpastes are multifunctional, delivering therapeutic benefits to combat a variety of oral 
conditions (e.g., caries, gingivitis, dentine hypersensitivity, erosive tooth wear) while also offering 
cosmetic benefits such as control of extrinsic enamel staining or inhibition of oral malodour. The 
incorporation of ‘cosmetic’ ingredients allows toothpastes to be tailored to an individual’s 
requirements; however, consideration must be given to ensure that the positive actions of 
therapeutic ingredients are not negated by the addition of such ingredients.  
An important cosmetic function of a toothpaste is to control extrinsic dental stain. Common 
approaches include the use of physical abrasives, such as particulate silica or alumina, or soluble 
chemical agents with affinity for calcium ions, such as condensed phosphates (e.g., pyrophosphate, 
tripolyphosphate or hexametaphosphate) that interfere with attachment of stain molecules to 
enamel surfaces [1]. Chemical cleaning agents are an attractive addition to a conventional 
toothpaste to augment the abrasive-based stain control system without increasing toothpaste 
abrasivity [2]. However, condensed polyphosphate agents have been reported to interfere with the 
bioactivity of fluoride by inhibiting the exchange of minerals at the enamel surface, thereby 
interfering with the ability of fluoride to remineralise enamel [1, 3-5]. Few long-term clinical studies 
exist to clarify whether condensed phosphates impair the anticaries properties of fluoride, those 
that do, have not indicated an effect [6, 7]. However, such observations may not necessarily be 
extrapolated to all phosphate classes and a polyphosphate that provides the tooth whitening 
benefits typical of the class, without impact on fluoride-promoted remineralisation, is therefore of 
great interest. 
Phytate is an organic polyphosphate ion naturally found in cereals and seeds where it is the principal 
storage molecule of phosphorous in plant tissues [8]. Chemically, phytate is similar to condensed 
phosphates by virtue of multiple phosphate groups, but in contrast to condensed (linear) 
phosphates, it is cyclic in nature with six phosphates groups bound to a cyclohexane ring (and no 
direct phosphate-phosphate bonds). Recently, a 12-week study has indicated enhanced stain 
removal ability for a toothpaste containing 0.85% w/w sodium phytate compared to a regular 
toothpaste [2]. Phytate may also offer caries protective benefits of its own. In vitro, phytate has 
been shown to modify the transport of ions across enamel and dentine surfaces, with potential 
benefits in terms of caries progression [9, 10] In animal caries studies, phytate has been shown to 
exhibit anticaries effects in the absence of fluoride [11].  
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A second important cosmetic function of a toothpaste is control of oral malodour. Zinc ions are 
commonly added to toothpaste formulations to reduce malodour by chemically binding to volatile 
odour molecules [12, 13] and by inhibiting malodour-generating plaque bacteria [14]. Zinc has an 
affinity for enamel surfaces via binding to surface phosphate groups and so also has the potential to 
interfere with fluoride’s action against caries [15, 16]. Since a further benefit of use of zinc 
toothpastes is a reduction in calculus formation [17] via inhibition of formation of apatites and their 
precursors [18], it has the potential to interfere with enamel remineralisation. In vitro mechanistic 
studies have demonstrated the potential for this to occur in both a positive and negative fashion [15, 
16]. Furthermore, like phytate, zinc may offer its own protection against demineralisation. Data from 
in vitro and in situ studies support this proposition [19, 20]. Overall, the effect of zinc on caries 
development is proposed to be neutral [6, 21]. 
It is important to understand the interaction of these ‘cosmetic’ agents on fluoride efficacy, 
separately and together, when formulated in a toothpaste. A program was undertaken to investigate 
the remineralisation/demineralisation effects of phytate and zinc on fluoride efficacy from 
toothpastes. Studies have already been performed to understand their effects on enamel 
remineralisation/demineralisation using a relatively simple, single-treatment ‘erosion’ in situ 
protocol [22, 23]. These studies showed significant inhibition of fluoride-induced remineralisation by 
phytate and by zinc. In the current study, a protocol based on an established longer-term in situ 
caries model [24] was employed to examine the effects of phytate (at two concentrations, the 
primary focus of the study) and zinc (the secondary focus) separately and together in a regular 
fluoride toothpaste on remineralisation and prevention of further demineralisation of enamel.  
 
Materials and Methods 
This was a single-centre, randomised, blinded (examiner and laboratory analyst), six-treatment, four-
period crossover, in situ study conducted at the Oral Health Research Institute of the Indiana 
University School of Dentistry, Indianapolis, Indiana, USA. The protocol was approved by the Indiana 
University Institutional Review Board (IRB #1512088822) and the study was conducted in accordance 
with the Declaration of Helsinki and the International Conference on Harmonization of Technical 
Requirements for Registration of Pharmaceuticals for Human Use. The study was registered at 
clinicaltrials.gov (NCT02751320). There were minor amendments to the protocol that did not affect 
study flow or outcomes. 
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Participants 
All participants provided written informed consent prior to screening. Participants aged 18–85 years 
were eligible for inclusion if they had good oral health and a removable bilateral maxillary partial 
denture with sufficient room in the posterior buccal flange areas to accommodate two enamel 
specimens and an unstimulated and stimulated salivary flow rate of at least 0.2 and 0.8 mL/min, 
respectively. Exclusion criteria included: pregnancy; breastfeeding; taken antibiotics or had received 
professional fluoride application in the 2 weeks prior to screening; use of fluoride supplements or 
mouth rinse; dental restorations in poor state of repair; active caries or moderate/severe 
periodontal disease; using a denture adhesive to secure the denture other than non-zinc Poligrip® 
(GSK Consumer Healthcare, Weybridge, UK). 
In situ remineralisation model 
This study used the in situ caries remineralisation model developed by Zero et al. [25, 26]. Human 
permanent teeth were cut into 4 × 4 mm enamel specimens, which were polished to create flat 
surfaces as described previously. Surface-softened lesions (A-lesions) were created according to a 
modified method of White [27] by immersing enamel specimens in 40 mL 0.05 mol/dm3 lactate 50% 
saturated with respect to hydroxyapatite and containing 0.2% (wt/vol) Carbopol® 907 (BF Goodrich, 
Cleveland, OH, USA) adjusted to pH 5.0 with KOH at 37°C for 24 h. Subsurface lesions (B-lesions) 
were prepared by demineralising enamel specimens at 37°C for 9 days in a solution containing 0.1 M 
lactate, 4.1 mM CaCl2, 8.0 mM KH2PO4 and 0.2% w/v Carbopol® 907, pH adjusted to pH 5.0 using KOH 
[28]. Lesions were deemed acceptable if lesioned areas displayed uniform opacity and surface shine 
on exposure to overhead light. Specimens were stored in a moist environment to prevent 
dehydration and were sterilised by ethylene oxide gas prior to insertion into dentures. 
At each treatment start visit, one A-lesion and one B-lesion enamel specimen was placed flush in 
each buccal flange area of the bilateral mandibular denture for a total of two of each specimen type 
per denture. Each enamel specimen was covered with Polyester Knit Fabric (Item P01628, Bard 
Peripheral Vascular, Tempe, AZ, USA) to encourage plaque formation [29, 30]. Specimens were 
mounted such that the surface was flush with the buccal flange surface and were luted in place using 
a light cured dental composite (Triad VLC material, Dentsply Int., York, PA, USA). Upon study 
completion, the denture was permanently repaired with acrylic. 
Study design and treatments 
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At the screening visit, participants provided written informed consent and their demographic details 
and medical and current medication history was recorded. They underwent an oral soft tissue (OST) 
and oral hard tissue (OHT) examination and their stimulated and unstimulated salivary flow rate was 
assessed. An OST examination was also performed before and after each treatment period; an OHT 
examination was performed following dental prophylaxis and at the end of each treatment period. 
Prior to each treatment period, participants received a dental prophylaxis using a non-fluoride 
prophylaxis and floss. They were issued with a washout toothpaste (Negative Control 0 ppm 
fluoride, as below) and study toothbrush (Aquafresh® Clean Control Everyday Clean™ toothbrush, 
GSK Consumer Healthcare, supplied new for each washout and treatment period). 
At the first treatment visit, eligible participants were randomised to a treatment sequence according 
to a schedule provided by the Biostatistics Department of GSK Consumer Healthcare. Given the 
number of treatment arms, an incomplete block design was employed to reduce the length of 
participation for each subject and so that all possible pairs of treatments were observed, ideally an 
equal number of times. Details of study treatments are provided in Table 1.  
Toothpastes were supplied in plain white tubes with a label containing protocol number, product 
code, directions of use/storage and emergency contact number. The examiner, laboratory analysts, 
study participants, study statistician, data management staff and other employees of the sponsor 
who could influence study outcomes were blinded to treatment allocation and order of treatment.  
Participants used 1.5 g (±0.1 g) of their assigned toothpaste twice a day, applied to a wet 
toothbrush, and brushed only their natural teeth for one timed minute, ensuring the enamel 
specimens were not brushed. They then rinsed with 15 mL tap water for approximately 10 s. The 
first brushing for each participant for each treatment period was under study site supervision with 
their brushing technique re-assessed at each treatment visit. Participants wore their mandibular 
partial denture for 24 h a day but could remove it for water-rinsing following eating and for cleaning, 
taking care to avoid brushing the specimens. Participants could not eat or drink anything for at least 
30 min following brushing and were instructed not to eat canned sardines during the study as they 
could contain high fluoride levels. Participants followed the brushing schedule for 28 days per 
treatment period and returned to the study centre at days 14 and 28 where the two A-lesion 
specimens and two B-lesion specimens were removed, respectively.  
There was a washout-period of approximately 1 week between each treatment period during which 
participants followed their usual dental hygiene practices for at least 4 days. They then returned to 
the study centre for a dental prophylaxis. For the 2–3 days prior to the treatment start visits, 
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participants discontinued all usual oral hygiene practices (with the exception of inter-dental 
cleaners) and used only the study washout fluoride-free toothpaste and toothbrush. For the study 
duration, participants were instructed not to use any other denture cleaning products or denture 
adhesive on the lower partial denture or a denture adhesive, with the exception of supplied, zinc 
free, Polygrip, on the upper partial or full denture.  
Outcome measures and their assessment 
The primary endpoint for analysis was percentage surface microhardness recovery (%SMHR) [31] of 
the A-lesions with the primary objective being to evaluate if %SMHR was related to sodium phytate 
dose. SMH was measured by assessing indentation lengths using a Wilson 2100 Hardness Tester 
(Norwood, MA, USA) equipped with a Knoop diamond, before (B) and after (D) in vitro 
demineralisation of the enamel specimens and after intraoral toothpaste treatment (R). Values were 
averaged across the two enamel specimens per participant to give a single observation. %SMHR was 
calculated as = [(D-R)/(D-B)]×100 [32]. 
Additional endpoints for the A-lesions were measurement of the amount of fluoride incorporated 
into the enamel (EFU) and the TMR-derived parameters of Z (integrated mineral loss in 
vol%min×m), L (lesion depth in m) and SZmax (surface zone mineral density in vol%min). For the B-
lesions, secondary endpoints evaluated included EFU, F (lesion fluorescence loss, determined using 
quantitative light-induced fluorescence [QLF]) and the TMR-derived variables of M (change from 
baseline integrated mineral loss), L (change from baseline lesion depth) and SZmax (change from 
baseline surface zone mineral density).  
TMR measurements were made by sectioning the enamel specimens into 100 µm plano-parallel thin 
slices using a Silverstone-Taylor Hard Tissue Microtome (Scientific Fabrications, Lafayette, CO, USA). 
Specimens were polished, mounted on plates and x-rayed at 20 kV and 30 mA at a distance of 42 cm 
for 65 min. Micrographs were examined by Zeiss EOM microscope using TMR software v.3.0.0.11 
(Inspektor Research Systems BV, Amsterdam, The Netherlands). Mineral content was calculated 
from the grey intensity levels of the section images [33, 34]. Lesions were required to have a 
baseline mineral loss (Z) of 2500 ±600 vol%min × μm and a maximum mineral density at the 
surface zone (SZmax) of at least 40 vol%min. After treatment, a further section was taken from each 
lesion specimen for radiography assessment. To avoid potentially compromising the primary 
endpoint, %SMHR of A-lesions, baseline TMR measures were not performed; TMR data for the A-
lesions represents the lesion condition at the end of treatment while TMR data for the B-lesions 
represents change from baseline. 
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Changes in mineral content (M), lesion depth (L) and maximum mineral density at the surface-
zone (SZmax) were calculated as respective post-treatment values minus baseline values. Positive 
numbers denote remineralisation, increase in lesion depth and increase in SZmax, respectively; 
negative numbers denote further demineralisation, decrease in lesion depth and decrease in SZmax, 
respectively. 
For QLF, the B-lesion specimens were air-dried for at least 10 min before QLF measurements were 
performed using the QLF-D Biluminator 2 (Inspektor Research, the Netherlands). A sound enamel 
reference area had previously been denoted/protected on each specimen through the use of clear 
nail varnish. Acquired QLF images were analysed using dedicated QLF Analysis software (C4 Research 
Software Suite, Inspektor Research Systems BV, Amsterdam, The Netherlands). Fbase values were 
recorded at a threshold level of 5%, i.e., a minimum of 5% fluorescence loss between sound and 
uncovered demineralised enamel. After completion of the 28-day treatment period, QLF images 
were obtained on all B-lesions again (Fpost). The change that occurred in lesion fluorescence loss 
(F) following treatment was calculated as follows: F = Fpost - Fbase, where positive numbers 
denote remineralisation, negative numbers denote further demineralisation.  
EFU was determined using the microdrill enamel biopsy technique, as previously described [35]. 
Four microdrill samples from each enamel specimen were pooled and a value for fluoride content 
determined. Participant-wise measurements were calculated separately for A- and B-lesions as the 
mean values from the two respective enamel blocks. 
Safety 
Assessments of tolerability were made with respect to OST abnormalities and adverse events (AEs) 
reported by participants following the first dental prophylaxis until 5 days following last 
administration of study treatment. Each AE was assessed for intensity (mild, moderate, severe) and 
whether it was related to study treatment, according to clinical judgement. Safety assessments were 
based on the safety population, defined as all participants who were randomised and received at 
least one dose of study toothpaste. 
Statistical analysis 
This was an exploratory study to examine the effects of phytate (at two concentrations, the primary 
focus of the study) and zinc (the secondary focus) separately and together in a regular fluoride 
toothpaste on remineralisation and prevention of further demineralisation of enamel. Given the 
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exploratory nature of this comparison, no formal sample size calculation was performed. However, 
to ensure validity of this established model (and permit comment on comparison between the 
fluoride toothpastes), a formal size calculation was performed on the Placebo and F-only controls. 
This study aimed to randomize approximately 62 participants to ensure approximately 50 completed 
the entire study. In this incomplete block design, with 50 evaluable participants this study had >90% 
power at a 5% significance level (using 2-sided testing) to detect differences between the Placebo 
and F-only groups for the main comparators (%SMHR for A-lesions, TMR [M] for B-lesions).   
The intent-to-treat (ITT) population, on which all efficacy analyses were performed, was defined as 
all participants who were randomised, received study toothpastes at least once and provide at least 
one post-baseline efficacy assessment. The per protocol (PP) population was defined as all 
participants in the ITT population who had at least one efficacy assessment considered unaffected 
by protocol violations.  
Validity of the study assessment measures were predefined as acceptable if there was a statistically 
significant difference (p < 0.05) between the F-only and Placebo toothpastes, favouring the former. If 
model analysis method validity was not achieved, no further analysis of any endpoint was performed 
using that technique. In all analyses, if a participant was missing an enamel specimen, the mean was 
computed over the available enamel specimens. All pairwise treatment comparisons were 
performed using 2-sided testing at the 5% significance level. The assumption of normality of 
residuals was investigated and met for all endpoints. No adjustment for multiple comparisons was 
employed as the primary comparison had been defined. 
%SMHR was analysed using an analysis of covariance (ANCOVA) model with participant as a random 
effect and fixed effects for study period and treatment. The covariates were based on participant-
level (mean across treatment periods) and period level (period level minus participant level) baseline 
and pre-treatment acid challenge enamel SMH/indentation lengths. Primary comparisons were: F-
only vs Placebo (validity of model, fluoride effect); 0.425% Phy/F vs F-only; 0.85% Phy/F vs F-only; 
0.425% Phy/F vs 0.85% Phy/F. Linear and quadratic contrasts were fitted to establish whether there 
was a dose-response relationship of phytate (0%, 0.425%, and 0.85% all containing 1150 ppm 
fluoride). Secondary comparisons were: 0.85% Phy/Zn/F vs Zn/F; Zn/F vs F-only; 0.85% Phy/F vs 
0.85% Phy/Zn/F.  
Participant-wise change in mineral content (M) of TMR values at week 4 and participant-wise EFU 
at 2 and 4 weeks were secondary efficacy variables. Participant-wise measurements were calculated 
as the mean values from the two enamel blocks for A- and B-lesions. Treatment comparisons were 
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performed using a mixed model ANCOVA including participant as a random effect and fixed effects 
for study period and treatment. It also included the participant-level (mean across treatment 
periods) baseline and period level (period level minus participant level) baseline Z measurement as 
covariates. EFU and F scores were analysed using analysis of variance (ANOVA) with participant as 
a random effect and fixed effects for study period and treatment for both A and B-lesions. Linear 
and quadratic contrasts were fitted to establish whether ther 
e was a dose-response relationship of phytate (0%, 0.425%, and 0.85% all containing 1150 ppm 
fluoride). Secondary comparisons were: 0.85% Phy/Zn/F vs F-only; Zn/F vs F-only; 0.85% Phy/F vs 
0.85% Phy/Zn/F. 
All TMR parameters (change in mineral content [M], change in the lesion depth [L] and maximum 
mineral density at the surface-zone) for A-lesions at week 2, change in the lesion depth (L), 
maximum mineral density at the surface-zone of TMR and change in lesion fluorescence loss (F) 
of the B-lesions at week 4 were exploratory efficacy variables. All TMR parameters at week 2 for A-
lesions were analysed the same way as EFU. Change in the lesion depth (L), maximum mineral 
density at the surface-zone and change in lesion fluorescence loss (F) of the B-lesions were 
analysed in the same way as M of TMR at week 4. Baseline (participant and period level) lesion 
depth, SZmax and F were used as covariates, respectively. 
 
Results 
Of 58 screened participants, 45 were randomised to treatment and 42 completed the study between 
8 Feb 2016 and 11 Aug 2016 [Figure 1]. Of the randomised participants, 55.6% were female and 
mean age was 64.3 (range 36–80) years. The study failed to recruit sufficient participants per the 
planned recruitment target. This was due to unavailability of enough participants with appliances of 
adequate size to support four enamel specimens as required. The study was designed so that all 
possible pairs of treatments would be observed, ideally an equal number of times. However, due to 
participant recruitment and early withdrawal, where subjects did not complete all periods, the 
numbers in each treatment comparison were not exactly balanced [Figure 1]. Given that this was an 
exploratory study, and no formal sample-size calculation had been performed for the primary focus 
(phytate dose response), the decision was made to continue the study with the available 
participants. The decrease in power due to the small reduction in the number of planned 
randomised participants was considered to be modest. 
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Surface Microhardness Recovery (%SMHR) 
Indentation lengths and %SMHR for A-lesions are shown in Table 2 with adjusted mean %SMHR 
shown in Figure 2A. All groups demonstrated statistically significant (p<0.0001) remineralisation 
except Placebo (p=0.1093). Table 3 shows that the %SMHR for the F-only group was statistically 
significantly higher than the Placebo, demonstrating model validity for this measure. No significant 
differences were observed between the fluoride toothpaste groups, thus the addition of phytate at 
0.425% or 0.85% did not statistically significantly attenuate or improve the effect of fluoride. The 
linear and quadratic tests did not indicate a dose-response trend of phytate. The addition of 0.3% 
ZnCl2 to the 0.85% sodium phytate formulation combined with 1150 ppm fluoride produced no 
significant change in %SMHR, nor did it significantly attenuate the 1150 ppm fluoride effect in the 
absence of phytate.  
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TMR values: A and B-lesions 
Adjusted mean TMR values are shown in Figure 3 with results detailed in Supplemental Table 1. TMR 
values for the F-only group were statistically significantly higher than the Placebo (p<0.05 for all) 
demonstrating model validity for this measure. Consistent with %SMHR, no differences were 
observed between the fluoride toothpaste groups. The linear and quadratic trends indicated no clear 
dose-response of phytate.  
EFU and QLF: A and B-lesions 
Results are shown in Figure 2B (F), 2C (A-lesion EFU) and 2D (B-lesion EFU) along with 
Supplemental Table 2. The F-only treatment was statistically significantly superior to the Placebo for 
all measures (p<0.001) demonstrating model validity. Consistent with the other measures, no 
statistically significant differences were observed between the fluoride toothpaste groups, with the 
linear and quadratic trends indicating no clear dose-response of phytate. Positive F values 
demonstrated remineralisation of lesions in all groups.  
Safety 
Supplemental Table 3 details all treatment-emergent AEs (TEAEs). Overall 79 TEAEs were reported 
by 57 participants, of which 51 TEAEs were oral. However, few TEAEs were considered treatment 
related, one each in the 0.85% Phy/F group (angular cheilitis), 0.85% Phy/Zn/F group (dry mouth) 
and F-only (lip dry) groups. Two non-treatment related TEAEs (one of mild urinary tract infection, 
one [serious and severe] of invasive ductal carcinoma in breast) led to participant withdrawal. All 
other TEAEs were mild or moderate in intensity and most had resolved by the end of the study.  
 
Discussion 
The primary aim of this study was to evaluate the potential impact of phytate on the ability of 
fluoride to reduce dental caries. The in situ model design employed in this clinical study has 
previously been used as a surrogate predictor of clinical efficacy for caries [24, 31]. The principal 
advantage of this model is that efficacy information on the early stages of the caries process can be 
obtained in a relatively short time-scale in well-controlled conditions. A further advantage of the 
study design is the incorporation of two lesion types. As seen previously, the B-lesions underwent 
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net demineralisation [28] whereas the A-lesions underwent net remineralisation [24]. Since fluoride 
exerts its anti-caries effect by both reducing demineralisation and promoting remineralisation, it is 
advantageous to be able to study both phenomena simultaneously. 
In this study, a three-level dose-response for phytate (0%, 0.425% and 0.85% sodium phytate) was 
employed to determine its impact on fluoride’s ability to promote remineralisation and inhibit 
demineralisation of enamel in the oral cavity, and hence the potential impact on fluoride’s anticaries 
activity. The effect of zinc was investigated using a 0.3% ZnCl2 formulation (with 0.5% sodium citrate 
added to stabilise zinc ions in solution). Other formulations were included to allow an investigation 
of any modulation of the effect of phytate by zinc and vice versa. This treatment set also allowed 
study of the effect of phytate (at 0.85% sodium phytate) and zinc in combination on fluoride’s 
actions in the model.    
While the study failed to recruit sufficient participants per the planned recruitment target, a 
statistically significant difference between the 0 ppm (Placebo) and 1150 ppm fluoride (F-only) 
toothpastes (negative and positive controls, respectively) was observed for all endpoints, for both 
lesion types. Therefore, all endpoints were regarded as valid and permit comment on the potential 
fluoride efficacy of formulations tested. None of the endpoints showed a statistically significant 
difference between the positive control (F-only) and any of the treatments containing phytate or 
zinc for either of the lesion types. Further, there was no clear dose-response of phytate (within the 
range of 0–0.85%) on any of the endpoints investigated, as evidenced by no statistically significant 
linear or quadratic contrasts. Thus, within the limitations of this exploratory study (no formal 
sample-size calculation on the primary focus and a potentially modest reduction in the expected 
power), neither phytate nor zinc ions, alone or together, appear to meaningfully affect fluoride’s 
ability to promote remineralisation or prevent demineralisation of enamel in this model, within the 
dose-range tested.  
Notwithstanding this conclusion, there are trends in the data with respect to phytate. In many 
measures, amongst the phytate dose-response toothpastes, the phytate-containing formulations 
performed numerically less well than the F-only formulation (A-lesions: %SHMR, all TMR measures, 
EFU; B-lesions: TMR M and L, QLF and EFU). This observation suggests that there may be a slight 
negative impact of phytate on fluoride efficacy in this model and warrants further investigation. 
In relation to other studies performed on phytate [23] or zinc [22], these results stand in marked 
contrast. In a single-treatment erosion orientated in situ study (conducted on lesions representative 
of erosive lesions [plaque-free]), phytate (at the 0.85% sodium phytate concentration used in this 
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study) significantly inhibited fluoride-promoted remineralisation, and also appeared to inhibit 
fluoride’s ability to protect against demineralisation [23]. In a similar zinc-oriented single-treatment 
in situ study (also using the 0.3% zinc chloride concentration used in this study), zinc inhibited 
fluoride-promoted remineralisation, but, intriguingly appeared to add to fluoride’s ability to protect 
against demineralisation [22]. The single-treatment erosion-orientated in situ model is focused on 
exploring recovery from the very earliest signs of enamel demineralisation. However, the strength of 
the effects observed in the erosion-focused in situ studies make it remarkable that the overall effect 
of phytate and zinc (individually or together) was marginal at most in the present study. For zinc, it 
may well be that the observed additive effect to fluoride in protecting against demineralisation is 
important in the daily intra-oral remineralisation/demineralisation cycle, balancing out any inhibition 
of remineralisation. Perhaps more likely is the fact that the single-treatment model uses plaque-free 
enamel surfaces, whereas the present study measures effects on plaque-covered surfaces. So, while 
the plaque-free model allows understanding of potential enamel chemistry from treatments to be 
studied, any such effects may be much less relevant when the surface is covered by a dense plaque 
biofilm, as was the case for the model used in this study and is usual for nascent caries lesions [36]. 
This study involved a variety of different techniques to examine effects on enamel. Interestingly, 
while the TMR-derived M values show that the B-lesions demineralised further during the study, 
the QLF data suggest they have remineralised for all treatment groups. This result appears 
surprising; however, it does mirror previous observations [28]. One explanation may be that QLF is 
more sensitive to the condition of the surface zone than expected. Whilst M values for these 
lesions showed overall demineralisation compared to baseline, the SZmax values showed that the 
surface zone remineralised compared to baseline. This hypothesis would benefit from further 
investigation.  
In conclusion, the present in situ caries model study found no statically significant difference in 
%SMHR, TMR parameters, EFU or QLF measures between the fluoride toothpastes with or without 
phytate. These results suggest that phytate, incorporated at up to 0.85% sodium phytate into a 
fluoride or fluoride/zinc toothpaste, has little impact on the ability of fluoride to affect 
remineralisation of surface-softened (A-) lesions or prevent demineralisation of subsurface (B-) 
lesions. Similarly, the results also show that the presence of zinc (as zinc chloride at 0.3%) does not 
impact fluoride efficacy in this model. However, these observations should be confirmed in a 
formally powered in situ study. All study treatments were generally well-tolerated. 
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Figure 1: Participant disposition throughout study 
 
Figure 2: Adjusted mean (standard error) of A) %SMHR for A-lesions, B) change in QLF for B-lesions, 
C) EFU for A-lesions and D) EFU for B-lesions (ITT population) 
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Figure 3: TMR values for study treatments (A–C: A-lesions, D–F: B-lesions; adjusted mean ±standard 
error): A) Integrated mineral loss (Z), B) Lesion depth and C) SZmax; D) Integrated mineral loss (Z), 
E) Lesion depth, F) SZmax (ITT population) 
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Table 1: Description of study treatments* 
Name Phytate (as sodium 
phytate, w/w) 
Zinc (as zinc 
chloride, w/w)** 
Fluoride (ppm 
F, as NaF) 
0.425% Phy/F 0.425% w/w - 1150 
0.85% Phy/F 0.85% w/w - 1150 
0.85% Phy/Zn/F 0.85% w/w 0.3% 1150 
Placebo  - - - 
F-only - - 1150 
Zn/F - 0.3% 1150 
*All toothpastes were formulated in a silica abrasive base that contained sodium lauryl sulphate as 
the primary surfactant; **Zinc-containing toothpastes included sodium citrate to stabilise the ionic 
form of zinc. 
 
Table 2: Indentation lengths and %SMHR means for A-lesions (ITT population) 
Indentation lengths (SE) 0.425% Phy/F 0.85% Phy/F 0.85% Phy/Zn/F Placebo     F-only      Zn/F 
Baseline 43.73 (0.071) 43.49 (0.081) 43.54 (0.076) 43.57 (0.072) 43.89 (0.076) 43.34 (0.074) 
After demin 114.92 (0.599) 114.82 (0.608) 114.30 (0.578) 113.95 (0.594) 114.62 (0.601) 114.29 (0.560) 
After treatment 96.36 (0.990) 95.60 (0.924) 97.33 (0.924) 108.57 (1.047) 94.32 (1.077) 93.77 (0.975) 
%SMHR Mean (95% CI) 27.42 (20.55, 34.29) 25.20 (18.33, 32.08) 25.89 (19.00, 32.79) 5.54 (-1.26, 12.35) 28.50 (21.55, 35.45) 26.35 (19.44, 33.25) 
P value <0.0001 <0.0001 <0.0001 0.1093 <0.0001 <0.0001 
 
 
Table 3: Differences in %SMHR for A-lesions (ITT population) 
Treatment comparison Adjusted mean diff (95% CI) p-value (% change**) 
Linear contrast* P = 0.3555  
Quadratic contrast* P = 0.8545  
F-only vs Placebo 22.96 (16.02, 29.90) <.0001 (414.3%) 
0.425% Phy/F    vs F-only -1.09 (-8.11, 5.94) 0.7603 (-3.8%) 
0.85% Phy/F 2.21 (-4.81, 9.23) 0.5335 (8.8%) 
0.85% Phy/F     vs F-only -3.30 (-10.34, 3.74) 0.3555 (-11.6%) 
0.85% Phy/Zn/F -0.69 (-7.65, 6.27) 0.8443 (-2.7%) 
0.85% Phy/Zn/F      vs      Zn/F -0.45 (-7.46, 6.55) 0.8985 (-1.7%) 
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Zn/F                   vs      F-only -2.16 (-9.34, 5.03) 0.5533 (-7.6%) 
*0.425% Phy/F, 0.85% Phy/F, F-only; **Second treatment used as reference in calculating 
(Difference/Reference)*100 
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